Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$7.61 - $8.63 $2,092 - $2,373
-275 Reduced 2.65%
10,118 $77,000
Q4 2023

Jan 16, 2024

SELL
$5.7 - $9.14 $19,334 - $31,002
-3,392 Reduced 24.61%
10,393 $91,000
Q2 2023

Jul 25, 2023

SELL
$3.14 - $6.61 $94 - $198
-30 Reduced 0.22%
13,785 $91,000
Q1 2023

Apr 14, 2023

SELL
$2.97 - $4.81 $6,424 - $10,404
-2,163 Reduced 13.54%
13,815 $47,000
Q4 2022

Feb 08, 2023

BUY
$2.63 - $3.45 $4,720 - $6,192
1,795 Added 12.66%
15,978 $44,000
Q1 2022

May 11, 2022

SELL
$4.27 - $6.27 $28,822 - $42,322
-6,750 Reduced 32.25%
14,183 $67,000
Q4 2021

Feb 08, 2022

SELL
$5.7 - $8.48 $22,230 - $33,072
-3,900 Reduced 15.7%
20,933 $126,000
Q3 2021

Nov 02, 2021

SELL
$5.52 - $15.83 $6,585 - $18,885
-1,193 Reduced 4.58%
24,833 $150,000
Q2 2021

Aug 11, 2021

BUY
$9.02 - $12.72 $25,057 - $35,336
2,778 Added 11.95%
26,026 $326,000
Q1 2021

May 14, 2021

BUY
$8.48 - $11.28 $13,720 - $18,251
1,618 Added 7.48%
23,248 $239,000
Q4 2020

Feb 12, 2021

BUY
$5.32 - $10.17 $115,071 - $219,977
21,630 New
21,630 $196,000
Q4 2018

Feb 11, 2019

SELL
$1.15 - $6.45 $74,552 - $418,140
-64,828 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$3.22 - $6.33 $10,854 - $21,338
3,371 Added 5.49%
64,828 $401,000
Q2 2018

Jul 30, 2018

BUY
$5.39 - $8.96 $331,253 - $550,654
61,457 New
61,457 $393,000
Q1 2018

Apr 16, 2018

SELL
$6.69 - $17.96 $381,577 - $1.02 Million
-57,037 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$10.87 - $13.9 $35,805 - $45,786
3,294 Added 6.13%
57,037 $719,000
Q3 2017

Oct 26, 2017

SELL
$11.86 - $17.34 $16,094 - $23,530
-1,357 Reduced 2.46%
53,743 $638,000
Q2 2017

Aug 15, 2017

BUY
N/A
55,100
55,100 $825,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $999M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.